Enoxaparin sodium injection

DRUG4 trials

Sponsors

Beijing Suncadia Pharmaceuticals Co., Ltd, PT Bio Farma, Livzon Pharmaceutical Group Inc.

Conditions

Circulatory DiseaseEffect of DrugPrevention of Arterial and Venous ThrombosisPrevention of Venous Thromboembolism After Knee ArthroplastySafety Issues

Phase 2

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

CompletedNCT05752461

Beijing Suncadia Pharmaceuticals Co., LtdPrevention of Venous Thromboembolism After Knee Arthroplasty

Start: 2023-04-12End: 2024-06-25Updated: 2025-01-20

Phase II Clinical Study of H001 Capsule in the Prevention of Venous Thromboembolism After Total Knee Arthroplasty

RecruitingNCT06963320

Livzon Pharmaceutical Group Inc.Circulatory Disease

Start: 2025-01-20End: 2025-07-30Target: 320Updated: 2025-05-09

Phase 3

A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

CompletedNCT06825416

Beijing Suncadia Pharmaceuticals Co., LtdPrevention of Arterial and Venous Thrombosis

Start: 2025-03-16End: 2026-04-23Updated: 2026-08-28

Phase 4

Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients

CompletedNCT06114641

PT Bio FarmaEffect of Drug, Safety Issues

Start: 2023-06-01End: 2024-08-26Updated: 2025-06-06